SignalHF vs qXR-CTR
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, SignalHF, focuses on predicting heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices for proactive patient management. In contrast, Tool B, qXR-CTR, automates cardiothoracic ratio measurement from chest X-rays to aid in assessing heart size and potential heart failure risk. While both contribute to heart failure care, they utilize distinct data sources and serve different primary functions: predictive monitoring versus diagnostic imaging analysis.
Choose SignalHF if…
Choose SignalHF if your primary objective is to proactively prevent heart failure hospitalizations in patients already equipped with cardiac implantable electronic devices (CIEDs). This tool excels at continuous, manufacturer-agnostic monitoring and risk stratification by analyzing real-time physiological data to enable early intervention and personalized care plans.
View SignalHF →Choose qXR-CTR if…
Choose qXR-CTR if you require an efficient, AI-powered solution for automated cardiothoracic ratio (CTR) measurement directly from chest X-ray images. This tool is ideal for rapid initial screening or diagnostic support within radiology workflows, aiding in the quick assessment of heart size and identification of potential heart failure risk based on imaging data.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SignalHF | qXR-CTR |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | SaaS | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SignalHF | qXR-CTR |
|---|---|---|
| Name | SignalHF | qXR-CTR |
| Company | Implicity | Qure.ai Technologies |
| Primary Function | Predicts heart failure hospitalizations within 30 days by analyzing CIED data | Automates measurement of cardiothoracic ratio (CTR) from chest X-rays to assess heart size and potential heart failure risk |
| Data Input | Data from various cardiac implantable electronic devices (CIEDs), physiological data, demographics, lead measurements, episodes, and therapies | Chest X-ray images |
| Key Output/Prediction | Automatic alerts for care teams based on risk scores for heart failure hospitalization | Automated measurement of cardiothoracic ratio (CTR) |
| Categories | Cardiology AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring SignalHF and qXR-CTR.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
SignalHF by Implicity is an AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices (CIEDs). In contrast, qXR-CTR by Qure.ai automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, which aids in assessing heart size and potential heart failure risk.
SignalHF analyzes physiological data, demographics, lead measurements, episodes, and therapies collected from compatible CIEDs such as pacemakers, ICDs, and CRTs. qXR-CTR, on the other hand, specifically analyzes posterior-anterior chest X-ray images to calculate the cardiothoracic ratio.
SignalHF generates automatic alerts for care teams based on risk scores, predicting heart failure hospitalizations within 30 days to enable early intervention and personalized care plans. qXR-CTR provides an automated measurement of the cardiothoracic ratio, which is a diagnostic aid for assessing heart size and identifying potential heart failure risk.
SignalHF offers a unified platform for centralizing cardiac implantable device data and provides AI-driven alert management to filter and highlight relevant events for care teams. qXR-CTR is a software that can be deployed in cloud, on-premise, or hybrid environments, integrating into existing radiology workflows to automate CTR assessment from chest X-ray images.
SignalHF is primarily designed for cardiology specialists, focusing on heart failure care with predictive AI. qXR-CTR serves both cardiology and radiology specialties, as it involves AI-powered chest X-ray analysis for cardiac assessment.
Yes, SignalHF is manufacturer-agnostic and compatible with various cardiac implantable electronic devices (CIEDs), including pacemakers, ICDs, and CRTs from different manufacturers like Biotronik, Boston Scientific, and Medtronic.